gene literature_direction meddra_code meddra_name meddra_type combined_effect Lit_association_ID ACHE inhibition 10013654 Drug abuse PT abuse potential 1 ACHE inhibition 10002974 Apnoea PT apnea 2 ACHE inhibition 10003591 Ataxia PT ataxia 3 ACHE inhibition 10003840 Autonomic nervous system imbalance PT autonomic dysfunction 4 ACHE inhibition 10005734 Blood pressure decreased PT blood pressure decreased 5 ACHE inhibition 10005750 Blood pressure increased PT blood pressure increased 6 ACHE inhibition 10047513 Vision blurred PT blurred vision 7 ACHE inhibition 10062530 Increased bronchial secretion PT bronchial secretions increased 8 ACHE inhibition 10006482 Bronchospasm PT bronchoconstriction 9 ACHE inhibition 10057668 Cognitive disorder PT cognitive deficit 10 ACHE inhibition 10010071 Coma PT coma 11 ACHE inhibition 10010774 Constipation PT constipation 12 ACHE inhibition 10039906 Seizure PT convulsions 13 ACHE inhibition 10011906 Death PT death 14 ACHE inhibition 10017367 Frequent bowel movements PT defecation increased 15 ACHE inhibition 10012735 Diarrhoea PT diarrhea 16 ACHE inhibition 10034701 Peroneal nerve palsy PT foot drop 17 ACHE inhibition 10052105 Gastrointestinal hypomotility PT gastrointestinal motility decreased 18 ACHE inhibition 10010774 Constipation PT gastrointestinal motility decreased 18 ACHE inhibition 10017944 Gastrointestinal disorder PT gastrointestinal motility decreased 18 ACHE inhibition 10052402 Gastrointestinal hypermotility PT gastrointestinal motility increased 19 ACHE inhibition 10017944 Gastrointestinal disorder PT gastrointestinal motility increased 19 ACHE inhibition 10012735 Diarrhoea PT gastrointestinal motility increased 19 ACHE inhibition 10019301 Heart rate decreased PT heart rate decreased 20 ACHE inhibition 10019303 Heart rate increased PT heart rate increased 21 ACHE inhibition 10023644 Lacrimation increased PT lacrimation 22 ACHE inhibition 10027940 Mood altered PT mood change 23 ACHE inhibition 10044565 Tremor PT muscle tremor 24 ACHE inhibition 10028813 Nausea PT nausea 25 ACHE inhibition 10033557 Palpitations PT palpitations 26 ACHE inhibition 10033799 Paralysis PT paralysis 27 ACHE inhibition 10029331 Neuropathy peripheral PT peripheral neuropathy 28 ACHE inhibition 10027646 Miosis PT pupil diameter decreased 29 ACHE inhibition 10039424 Salivary hypersecretion PT salivation increased 30 ACHE inhibition 10020642 Hyperhidrosis PT sweating 31 ACHE inhibition 10033775 Paresthesia PT tingling/weakness in limbs 32 ACHE inhibition 10028372 Muscular weakness PT tingling/weakness in limbs 32 ACHE inhibition 10059896 Urine output increased PT urine excretion increased 33 ACHE inhibition 10047700 Vomiting PT vomiting 34 ADORA1 activation 10003671 Atrioventricular block PT atrioventricular block 35 ADORA1 activation 10005734 Blood pressure decreased PT blood pressure decreased 36 ADORA1 activation 10006093 Bradycardia PT bradycardia 37 ADORA1 activation 10003119 Arrhythmia PT cardiac arrhythmia 38 ADORA1 activation 10011906 Death PT death 39 ADORA1 activation 10007554 Cardiac failure PT heart failure 40 ADORA1 activation 10019301 Heart rate decreased PT heart rate decreased 41 ADORA1 activation 10053469 Analgesic therapy PT pain decreased 42 ADORA1 inhibition 10039906 Seizure PT convulsions 43 ADORA1 inhibition 10046672 Urine sodium increased PT urinary sodium excretion increased 44 ADORA1 inhibition 10062226 Urine analysis abnormal PT urinary sodium excretion increased 44 ADORA1 inhibition 10059896 Urine output increased PT urine excretion increased 45 ADORA2A activation 10005734 Blood pressure decreased PT blood pressure decreased 46 ADORA2A activation 10047141 Vasodilatation PT coronary vasodilation 47 ADORA2A activation 10019303 Heart rate increased PT heart rate increased 48 ADORA2A activation 10021097 Hypotension PT hypotension 49 ADORA2A activation 10035517 Platelet aggregation decreased PT platelet aggregation decreased 50 ADORA2A activation 10005140 Bleeding time prolonged PT platelet aggregation decreased 50 ADORA2A activation 10021089 Hyporeflexia PT reflex decreased 51 ADORA2A inhibition 10024421 Libido increased PT arousal 52 ADORA2A inhibition 10058929 Disturbance in sexual arousal PT arousal 52 ADORA2A inhibition 10005750 Blood pressure increased PT blood pressure increased 53 ADORA2A inhibition 10022437 Insomnia PT insomnia 54 ADORA2A inhibition 10044565 Tremor PT nervousness (tremors & agitation) 55 ADORA2A inhibition 10029216 Nervousness PT nervousness (tremors & agitation) 55 ADORA2A inhibition 10001497 Agitation PT nervousness (tremors & agitation) 55 ADORA2A inhibition 10035518 Platelet aggregation increased PT platelet aggregation increased 56 ADORA3 activation 10006482 Bronchospasm PT bronchoconstriction increased 57 ADORA3 activation 10011953 Decreased activity PT locomotor activity decreased 59 ADORA3 activation 10061296 Motor dysfunction PT locomotor activity decreased 59 ADORA3 activation 10053469 Analgesic therapy PT pain decreased 60 ADORA3 inhibition 10020751 Hypersensitivity PT allergic conditions 61 ADORA3 inhibition 10039906 Seizure PT convulsions increased 62 ADORA3 inhibition 10003553 Asthma PT enhanced mediator release could asthma increased 63 ADRA1A activation 10005750 Blood pressure increased PT blood pressure increased 64 ADRA1A activation 10003119 Arrhythmia PT cardiac arrhythmia 65 ADRA1A activation 10007596 Cardiac output increased PT cardiac contractility increased 66 ADRA1A activation 10062991 Positive cardiac inotropic effect PT cardiac positive ionotropy 67 ADRA1A activation 10052341 Impaired insulin secretion PT insulin release decreased 68 ADRA1A activation 10005613 Blood insulin decreased PT insulin release decreased 68 ADRA1A activation 10028521 Mydriasis PT pupil diameter increased 69 ADRA1A activation 10028293 Muscle contractions involuntary PT smooth muscle contraction 70 ADRA1A activation 10072810 Vascular wall hypertrophy PT vascular hypertrophy 71 ADRA1A inhibition 10005734 Blood pressure decreased PT blood pressure decreased 72 ADRA1A inhibition 10007558 Cardiac failure chronic PT chronic heart failure 73 ADRA1A inhibition 10013573 Dizziness PT dizziness 74 ADRA1A inhibition 10019303 Heart rate increased PT heart rate increased 75 ADRA1A inhibition 10020772 Hypertension PT hypertension 76 ADRA1A inhibition 10040477 Sexual dysfunction PT impact on various aspects of sexual function 77 ADRA1A inhibition 10031127 Orthostatic hypotension PT orthostatic hypotension 78 ADRA1A inhibition 10038967 Retrograde ejaculation PT retrograde ejaculation 79 ADRA1A inhibition 10021118 Hypotonia PT smooth muscle tone decreased 80 ADRA2A activation 10005613 Blood insulin decreased PT blood insulin decreased 81 ADRA2A activation 10005734 Blood pressure decreased PT blood pressure decreased 82 ADRA2A activation 10005910 Body temperature decreased PT body temperature decreased 83 ADRA2A activation 10021518 Impaired gastric emptying PT gastric emptying decreased 84 ADRA2A activation 10019301 Heart rate decreased PT heart rate decreased 85 ADRA2A activation 10020772 Hypertension PT hypertension heart failure increased 86 ADRA2A activation 10027175 Memory impairment PT memory decreased 87 ADRA2A activation 10029750 Norepinephrine decreased PT noradrenaline release decreased 88 ADRA2A activation 10053469 Analgesic therapy PT pain decreased 89 ADRA2A activation 10028521 Mydriasis PT pupil diameter increased 90 ADRA2A activation 10020635 Hyperglycemia PT resulting in hyperglycemia 91 ADRA2A activation 10039897 Sedation PT sedation 92 ADRA2A activation 10041349 Somnolence PT sedation 92 ADRA2A inhibition 10005614 Blood insulin increased PT blood insulin increased 94 ADRA2A inhibition 10039906 Seizure PT convulsions increased 95 ADRA2A inhibition 10052402 Gastrointestinal hypermotility PT gastrointestinal motility increased 96 ADRA2A inhibition 10017944 Gastrointestinal disorder PT gastrointestinal motility increased 96 ADRA2A inhibition 10012735 Diarrhoea PT gastrointestinal motility increased 96 ADRA2A inhibition 10074218 Intestinal transit time increased PT gastrointestinal transit increased 97 ADRA2A inhibition 10017944 Gastrointestinal disorder PT gastrointestinal transit increased 97 ADRA2A inhibition 10012735 Diarrhoea PT gastrointestinal transit increased 97 ADRA2A inhibition 10019303 Heart rate increased PT heart rate increased 98 ADRA2A inhibition 10020772 Hypertension PT hypertension heart failure increased 99 ADRA2B activation 10005750 Blood pressure increased PT blood pressure increased 100 ADRA2B activation 10028600 Myocardial ischemia PT cardiac ischemia 101 ADRA2B activation 10007554 Cardiac failure PT heart failure increased 102 ADRA2B activation 10019303 Heart rate increased PT heart rate increased 103 ADRA2B activation 10020772 Hypertension PT hypertension 104 ADRA2B activation 10053469 Analgesic therapy PT pain decreased 105 ADRA2B activation 10039897 Sedation PT sedation 106 ADRA2B activation 10041349 Somnolence PT sedation 106 ADRA2B activation 10044565 Tremor PT skeletal muscle tremor 107 ADRA2B activation 10047139 Vasoconstriction PT vasoconstriction of arteries 108 ADRA2B inhibition 10005734 Blood pressure decreased PT blood pressure decreased 109 ADRA2C activation 10028600 Myocardial ischemia PT cardiac ischemia 110 ADRA2C activation 10020772 Hypertension PT hypertension 111 ADRB1 activation 10006482 Bronchospasm PT bronchospasm 112 ADRB1 activation 10007596 Cardiac output increased PT cardiac contractility increased 113 ADRB1 activation 10007572 Cardiac hypertrophy PT cardiac hypertrophy 114 ADRB1 activation 10007595 Cardiac output decreased PT cardiac output decreased 115 ADRB1 activation 10021118 Hypotonia PT colon relaxation 116 ADRB1 activation 10061014 Blood electrolytes abnormal PT electrolyte disturbances 117 ADRB1 activation 10007554 Cardiac failure PT heart failure 118 ADRB1 activation 10019303 Heart rate increased PT heart rate increased 119 ADRB1 activation 10028594 Myocardial fibrosis PT myocardial fibrosis 121 ADRB1 activation 10021118 Hypotonia PT oesophagus relaxation 122 ADRB1 activation 10038559 Renin increased PT renin release increased 123 ADRB1 activation 10047290 Ventricular fibrillation PT ventricular fibrillation 124 ADRB1 inhibition 10005734 Blood pressure decreased PT blood pressure decreased 125 ADRB1 inhibition 10019301 Heart rate decreased PT heart rate decreased 126 ADRB2 activation 10005557 Blood glucose increased PT blood glucose increased 127 ADRB2 activation 10005724 Blood potassium decreased PT blood potassium decreased 128 ADRB2 activation 10006482 Bronchospasm PT bronchospasm 130 ADRB2 activation 10007515 Cardiac arrest PT cardiac arrest increased 131 ADRB2 activation 10007596 Cardiac output increased PT cardiac contractility increased 132 ADRB2 activation 10007572 Cardiac hypertrophy PT cardiac hypertrophy 133 ADRB2 activation 10007554 Cardiac failure PT heart failure 136 ADRB2 activation 10019303 Heart rate increased PT heart rate increased 137 ADRB2 activation 10028594 Myocardial fibrosis PT myocardiac fibrosis 138 ADRB2 activation 10047141 Vasodilatation PT peripheral vasodilation 139 ADRB2 activation 10014387 Electrocardiogram QT prolonged PT qtc interval increased 140 ADRB2 activation 10044565 Tremor PT skeletal muscle tremor 141 ADRB2 inhibition 10005734 Blood pressure decreased PT blood pressure decreased 142 ADRB2 inhibition 10005750 Blood pressure increased PT blood pressure increased 143 AGTR1 activation 10005750 Blood pressure increased PT blood pressure increased 144 AGTR1 activation 10033371 Pain PT pain increased 145 AGTR1 activation 10020568 Hyperesthesia PT pain increased 145 AGTR1 activation 10046671 Urine sodium decreased PT urinary sodium excretion decreased 146 AGTR1 activation 10062226 Urine analysis abnormal PT urinary sodium excretion decreased 146 AGTR1 inhibition 10005734 Blood pressure decreased PT blood pressure decreased 147 AGTR1 inhibition 10029305 Neurological disorders NEC HG cerebral complications 148 AGTR1 inhibition 10011906 Death PT death 149 AGTR1 inhibition 10073670 Hypocalvaria PT hypocalvaria 150 AGTR1 inhibition 10070531 Foetal growth restriction PT intrauterine growth retardation 151 AGTR1 inhibition 10024500 Limb malformation PT limb defects 152 AGTR1 inhibition 10030289 Oligohydramnios PT oligoamnios 153 AGTR1 inhibition 10053469 Analgesic therapy PT pain decreased 154 AGTR1 inhibition 10034130 Patent ductus arteriosus PT persistent patent ductus arteriosus 155 AGTR1 inhibition 10037407 Pulmonary hypoplasia PT pulmonary hypoplasia 156 AGTR1 inhibition 10038435 Renal failure PT renal failure 157 AGTR1 inhibition 10038687 Respiratory distress PT respiratory distress syndrome 158 AGTR1 inhibition 10046672 Urine sodium increased PT urinary sodium excretion increased 159 AGTR1 inhibition 10062226 Urine analysis abnormal PT urinary sodium excretion increased 159 AGTR1 inhibition 10059895 Urine output decreased PT urine excretion decreased 160 AGTR1 inhibition 10059896 Urine output increased PT urine excretion increased 161 AGTR2 activation 10046672 Urine sodium increased PT urinary sodium excretion increased 162 AGTR2 activation 10062226 Urine analysis abnormal PT urinary sodium excretion increased 162 AGTR2 activation 10059896 Urine output increased PT urine excretion increased 163 AGTR2 inhibition 10005734 Blood pressure decreased PT blood pressure decreased 164 AGTR2 inhibition 10029305 Neurological disorders NEC HG cerebral complications 165 AGTR2 inhibition 10011906 Death PT death 166 AGTR2 inhibition 10073670 Hypocalvaria PT hypocalvaria 167 AGTR2 inhibition 10070531 Foetal growth restriction PT intrauterine growth retardation 168 AGTR2 inhibition 10024500 Limb malformation PT limb defects 169 AGTR2 inhibition 10030289 Oligohydramnios PT oligoamnios 170 AGTR2 inhibition 10053469 Analgesic therapy PT pain decreased 171 AGTR2 inhibition 10034130 Patent ductus arteriosus PT persistent patent ductus arteriosus 172 AGTR2 inhibition 10037407 Pulmonary hypoplasia PT pulmonary hypoplasia 173 AGTR2 inhibition 10038435 Renal failure PT renal failure 174 AGTR2 inhibition 10038687 Respiratory distress PT respiratory distress syndrome 175 AR activation 10057671 Female sexual dysfunction PT andregenicity in females 176 AR activation 10012335 Dependence PT drug abuse/dependence 178 AR activation 10013654 Drug abuse PT drug abuse/dependence 178 AR activation 10020400 Hostility PT hostility increased 179 AR activation 10067125 Liver injury PT liver complications 180 AR activation 10028311 Muscle hypertrophy PT muscle mass increased 181 AR activation 10030095 Oedema PT oedema 182 AR activation 10060862 Prostate cancer PT prostate carcinoma increased 183 AR activation 10040979 Sleep apnoea syndrome PT sleep apnoea 184 AR inhibition 10002034 Anemia PT anemia 185 AR inhibition 10013496 Disturbance in attention PT attention decreased 186 AR inhibition 10047899 Weight increased PT body weight increased 187 AR inhibition 10027452 Metastases to bone PT bone metastasis 188 AR inhibition 10006002 Bone pain PT bone pain 189 AR inhibition 10006187 Breast cancer PT breast carcinoma increased 190 AR inhibition 10011906 Death PT death 191 AR inhibition 10012378 Depression PT depression 192 AR inhibition 10018800 Gynecomastia PT gynecomastia 193 AR inhibition 10028596 Myocardial infarction PT heart attack 194 AR inhibition 10060800 Hot flush PT hot flashes 195 AR inhibition 10061461 Erectile dysfunction PT impotence 196 AR inhibition 10022489 Insulin resistance PT insulin resistance 197 AR inhibition 10006298 Breast pain PT mastodynia 198 AR inhibition 10027175 Memory impairment PT memory decreased 199 AR inhibition 10031282 Osteoporosis PT osteoporosis 200 AR inhibition 10040477 Sexual dysfunction PT sexual dysfunction 201 AR inhibition 10003883 Azoospermia PT spermatogenesis decreased 202 AR inhibition 10041493 Spermatogenesis abnormal PT spermatogenesis decreased 202 AR inhibition 10005839 Blood triglycerides increased PT triglycerides increased 203 AVPR1A activation 10005750 Blood pressure increased PT blood pressure increased 204 AVPR1A activation 10005910 Body temperature decreased PT body temperature decreased 205 AVPR1A activation 10019301 Heart rate decreased PT heart rate decreased 206 AVPR1A activation 10021036 Hyponatremia PT hyponatraemia 207 AVPR1A activation 10028594 Myocardial fibrosis PT myocardial fibrosis 209 AVPR1A activation 10007572 Cardiac hypertrophy PT myocardial hypertrophy 210 AVPR1A activation 10046672 Urine sodium increased PT urinary sodium excretion increased 211 AVPR1A activation 10062226 Urine analysis abnormal PT urinary sodium excretion increased 211 AVPR1A activation 10016807 Fluid retention PT water retention in body 212 AVPR1A inhibition 10046671 Urine sodium decreased PT urinary sodium excretion decreased 215 AVPR1A inhibition 10062226 Urine analysis abnormal PT urinary sodium excretion decreased 215 AVPR1A inhibition 10047139 Vasoconstriction PT vasopressor 216 BDKRB1 activation 10011224 Cough PT cough 217 BDKRB1 activation 10061218 Inflammation PT inflammation 218 BDKRB1 activation 10033371 Pain PT nociception increased 219 BDKRB1 activation 10047141 Vasodilatation PT vasodilation 220 BDKRB2 activation 10005734 Blood pressure decreased PT blood pressure decreased 221 BDKRB2 activation 10006482 Bronchospasm PT bronchoconstriction 222 BDKRB2 activation 10011224 Cough PT cough 223 BDKRB2 activation 10061218 Inflammation PT inflammation 224 BDKRB2 activation 10033371 Pain PT nociception increased 225 BDKRB2 activation 10046672 Urine sodium increased PT urinary sodium excretion increased 226 BDKRB2 activation 10062226 Urine analysis abnormal PT urinary sodium excretion increased 226 BDKRB2 activation 10059896 Urine output increased PT urine excretion increased 227 BDKRB2 activation 10047141 Vasodilatation PT vasodilatation 228 BDKRB2 inhibition 10053469 Analgesic therapy PT pain decreased 229 BDKRB2 inhibition 10046671 Urine sodium decreased PT urinary sodium excretion decreased 230 BDKRB2 inhibition 10062226 Urine analysis abnormal PT urinary sodium excretion decreased 230 CACNA1C activation 10005750 Blood pressure increased PT blood pressure increased 231 CACNA1C activation 10007596 Cardiac output increased PT cardiac contractility increased 232 CACNA1C activation 10039906 Seizure PT convulsions increased 233 CACNA1C activation 10011953 Decreased activity PT locomotor activity decreased 234 CACNA1C activation 10061296 Motor dysfunction PT locomotor activity decreased 234 CACNA1C inhibition 10005734 Blood pressure decreased PT blood pressure decreased 235 CACNA1C inhibition 10007554 Cardiac failure PT cardiac contractility decreased 236 CACNA1C inhibition 10039906 Seizure PT convulsions increased 238 CACNA1C inhibition 10021097 Hypotension PT hypotension 239 CACNA1C inhibition 10014388 Electrocardiogram QT shortened PT possible shortening of qt interval of ecg 240 CACNA1C inhibition 10014374 Electrocardiogram PR shortened PT pr interval decreased 241 CACNA1C inhibition 10053657 Electrocardiogram PR prolongation PT pr interval increased 242 CACNA1C inhibition 10047141 Vasodilatation PT vascular relaxation 243 CCKAR activation 10000081 Abdominal pain PT abdominal pain hypersenstivity 244 CCKAR activation 10002855 Anxiety PT anxiety 245 CCKAR activation 10000060 Abdominal distension PT bloating 246 CCKAR activation 10005750 Blood pressure increased PT blood pressure increased 247 CCKAR activation 10005910 Body temperature decreased PT body temperature decreased 248 CCKAR activation 10063743 Hypophagia PT eating decreased 249 CCKAR activation 10061428 Decreased appetite PT eating decreased 249 CCKAR activation 10016256 Fatigue PT fatigue 250 CCKAR activation 10016766 Flatulence PT gas 252 CCKAR activation 10021518 Impaired gastric emptying PT gastric emptying decreased 253 CCKAR activation 10052402 Gastrointestinal hypermotility PT gastrointestinal motility increased 254 CCKAR activation 10017944 Gastrointestinal disorder PT gastrointestinal motility increased 254 CCKAR activation 10012735 Diarrhoea PT gastrointestinal motility increased 254 CCKAR activation 10074598 Intestinal transit time decreased PT gastrointestinal transit decreased 255 CCKAR activation 10010774 Constipation PT gastrointestinal transit decreased 255 CCKAR activation 10017944 Gastrointestinal disorder PT gastrointestinal transit decreased 255 CCKAR activation 10019303 Heart rate increased PT heart rate increased 256 CCKAR activation 10011953 Decreased activity PT locomotor activity decreased 257 CCKAR activation 10061296 Motor dysfunction PT locomotor activity decreased 257 CCKAR activation 10028813 Nausea PT nausea 258 CCKAR activation 10061900 Pancreatic enzymes increased PT pancreatic enzyme secretion 259 CCKAR activation 10022437 Insomnia PT sleep decreased 260 CCKAR inhibition 10008629 Cholelithiasis PT cholelethiasis 261 CCKAR inhibition 10008635 Cholestasis PT cholestasis 262 CCKAR inhibition 10020710 Hyperphagia PT eating increased 263 CCKAR inhibition 10021654 Increased appetite PT eating increased 263 CCKAR inhibition 10074218 Intestinal transit time increased PT intestinal transit increased 265 CCKAR inhibition 10017944 Gastrointestinal disorder PT intestinal transit increased 265 CCKAR inhibition 10012735 Diarrhoea PT intestinal transit increased 265 CHRM1 activation 10000081 Abdominal pain PT abdominal cramps 266 CHRM1 activation 10000486 Acidosis PT acidosis 267 CHRM1 activation 10005734 Blood pressure decreased PT blood pressure decreased 268 CHRM1 activation 10005750 Blood pressure increased PT blood pressure increased 269 CHRM1 activation 10047513 Vision blurred PT blurred vision 270 CHRM1 activation 10005911 Body temperature increased PT body temperature increased 271 CHRM1 activation 10062530 Increased bronchial secretion PT bronchorrhea 272 CHRM1 activation 10006482 Bronchospasm PT bronchospasm 273 CHRM1 activation 10019645 Hepatic congestion PT centrilobular liver congestion 274 CHRM1 activation 10067125 Liver injury PT centrilobular liver congestion 274 CHRM1 activation 10039906 Seizure PT convulsions increased 275 CHRM1 activation 10011224 Cough PT cough 276 CHRM1 activation 10016256 Fatigue PT exhaustion 277 CHRM1 activation 10062654 Foaming at mouth PT frothing 278 CHRM1 activation 10060041 Gastric pH decreased PT gastric acid secretion increased 279 CHRM1 activation 10020601 Hyperchlorhydria PT gastric acid secretion increased 279 CHRM1 activation 10019301 Heart rate decreased PT heart rate decreased 280 CHRM1 activation 10019303 Heart rate increased PT heart rate increased 281 CHRM1 activation 10020772 Hypertension PT hypertension 282 CHRM1 activation 10020843 Hyperthermia PT hyperthermia 283 CHRM1 activation 10022998 Irritability PT irritability 284 CHRM1 activation 10023644 Lacrimation increased PT lacrimation 285 CHRM1 activation 10019663 Hepatic failure PT liver failure 286 CHRM1 activation 10011953 Decreased activity PT locomotor activity decreased 287 CHRM1 activation 10061296 Motor dysfunction PT locomotor activity decreased 287 CHRM1 activation 10028334 Muscle spasms PT muscle cramps 289 CHRM1 activation 10015995 Eyelid ptosis PT ptosis 291 CHRM1 activation 10027646 Miosis PT pupil diameter decreased 292 CHRM1 activation 10038712 Respiratory rate increased PT respiratory rate increased 293 CHRM1 activation 10039424 Salivary hypersecretion PT salivation increased 294 CHRM1 activation 10020642 Hyperhidrosis PT sweating 295 CHRM1 activation 10043071 Tachycardia PT tachycardia 296 CHRM1 activation 10047700 Vomiting PT vomiting 297 CHRM1 inhibition 10047513 Vision blurred PT blurred vision 298 CHRM1 inhibition 10057668 Cognitive disorder PT cognitive function decreased 299 CHRM1 inhibition 10060040 Gastric pH increased PT gastric acid secretion decreased 301 CHRM1 inhibition 10000451 Achlorhydria PT gastric acid secretion decreased 301 CHRM1 inhibition 10019303 Heart rate increased PT heart rate increased 302 CHRM1 inhibition 10061296 Motor dysfunction PT locomotor activity increased 303 CHRM1 inhibition 10037211 Psychomotor hyperactivity PT locomotor activity increased 303 CHRM1 inhibition 10027175 Memory impairment PT memory decreased 304 CHRM2 activation 10000486 Acidosis PT acidosis 305 CHRM2 activation 10005734 Blood pressure decreased PT blood pressure decreased 306 CHRM2 activation 10005750 Blood pressure increased PT blood pressure increased 307 CHRM2 activation 10047513 Vision blurred PT blurred vision 308 CHRM2 activation 10005911 Body temperature increased PT body temperature increased 309 CHRM2 activation 10062530 Increased bronchial secretion PT bronchorrhea 310 CHRM2 activation 10006482 Bronchospasm PT bronchospasm 311 CHRM2 activation 10014388 Electrocardiogram QT shortened PT cardiac action potential duration decrease 312 CHRM2 activation 10011224 Cough PT cough 313 CHRM2 activation 10016256 Fatigue PT exhaustion 314 CHRM2 activation 10062654 Foaming at mouth PT frothing 315 CHRM2 activation 10019301 Heart rate decreased PT heart rate decreased 316 CHRM2 activation 10019303 Heart rate increased PT heart rate increased 317 CHRM2 activation 10022998 Irritability PT irritability 318 CHRM2 activation 10023644 Lacrimation increased PT lacrimation 319 CHRM2 activation 10028334 Muscle spasms PT muscle cramps 320 CHRM2 activation 10014374 Electrocardiogram PR shortened PT pr interval decreased 322 CHRM2 activation 10015995 Eyelid ptosis PT ptosis 323 CHRM2 activation 10037368 Pulmonary congestion PT pulmonary congestion 324 CHRM2 activation 10037394 Pulmonary hemorrhage PT pulmonary hemorrhage 325 CHRM2 activation 10027646 Miosis PT pupil diameter decreased 326 CHRM2 activation 10038710 Respiratory rate decreased PT respiratory rate decreased 327 CHRM2 activation 10038712 Respiratory rate increased PT respiratory rate increased 328 CHRM2 activation 10039424 Salivary hypersecretion PT salivation increased 329 CHRM2 activation 10020642 Hyperhidrosis PT sweating 330 CHRM2 inhibition 10006482 Bronchospasm PT bronchoconstriction 331 CHRM2 inhibition 10068180 Atrioventricular conduction time shortened PT cardiac conduction decreased (pr interval) 332 CHRM2 inhibition 10019303 Heart rate increased PT heart rate increased 333 CHRM2 inhibition 10049671 Negative cardiac inotropic effect PT negative inotropy 334 CHRM2 inhibition 10043071 Tachycardia PT tachycardia 335 CHRM2 inhibition 10044565 Tremor PT tremors 336 CHRM3 activation 10000081 Abdominal pain PT abdominal cramps 337 CHRM3 activation 10000486 Acidosis PT acidosis 338 CHRM3 activation 10005734 Blood pressure decreased PT blood pressure decreased 339 CHRM3 activation 10005750 Blood pressure increased PT blood pressure increased 340 CHRM3 activation 10047513 Vision blurred PT blurred vision 341 CHRM3 activation 10005911 Body temperature increased PT body temperature increased 342 CHRM3 activation 10006482 Bronchospasm PT "bronchoconstriction, bronchospasm" 343 CHRM3 activation 10062530 Increased bronchial secretion PT bronchorrhea 344 CHRM3 activation 10019645 Hepatic congestion PT centrilobular liver congestion 345 CHRM3 activation 10067125 Liver injury PT centrilobular liver congestion 345 CHRM3 activation 10011224 Cough PT cough 346 CHRM3 activation 10012735 Diarrhoea PT diarrhea 347 CHRM3 activation 10016256 Fatigue PT exhaustion 348 CHRM3 activation 10062654 Foaming at mouth PT frothing 349 CHRM3 activation 10028293 Muscle contractions involuntary PT gastrointestinal contraction 350 CHRM3 activation 10019301 Heart rate decreased PT heart rate decreased 351 CHRM3 activation 10019303 Heart rate increased PT heart rate increased 352 CHRM3 activation 10022998 Irritability PT irritability 353 CHRM3 activation 10023644 Lacrimation increased PT lacrimation 354 CHRM3 activation 10019663 Hepatic failure PT liver failure 355 CHRM3 activation 10028334 Muscle spasms PT muscle cramps 356 CHRM3 activation 10035598 Pleural effusion PT pleural effusions 358 CHRM3 activation 10015995 Eyelid ptosis PT ptosis 359 CHRM3 activation 10027646 Miosis PT pupil diameter decreased 360 CHRM3 activation 10038712 Respiratory rate increased PT respiratory rate increased 361 CHRM3 activation 10039424 Salivary hypersecretion PT salivation increased 362 CHRM3 activation 10020642 Hyperhidrosis PT sweating 363 CHRM3 activation 10048994 Bladder spasm PT urinary contraction 364 CHRM3 inhibition 10047513 Vision blurred PT blurred vision 365 CHRM3 inhibition 10010774 Constipation PT constipation 366 CHRM3 inhibition 10013781 Dry mouth PT dry mouth 367 CHRM3 inhibition 10021518 Impaired gastric emptying PT gastric emptying decreased 368 CHRM3 inhibition 10052105 Gastrointestinal hypomotility PT gastrointestinal motility decreased 369 CHRM3 inhibition 10010774 Constipation PT gastrointestinal motility decreased 369 CHRM3 inhibition 10017944 Gastrointestinal disorder PT gastrointestinal motility decreased 369 CHRM3 inhibition 10000389 Accommodation disorder PT interferes with ocular accommodation 370 CHRM3 inhibition 10074598 Intestinal transit time decreased PT intestinal transit decreased 371 CHRM3 inhibition 10010774 Constipation PT intestinal transit decreased 371 CHRM3 inhibition 10017944 Gastrointestinal disorder PT intestinal transit decreased 371 CHRM3 inhibition 10028521 Mydriasis PT pupil diameter increased 372 CHRM3 inhibition 10003068 Aptyalism PT salivation decreased 373 CHRM4 activation 10005734 Blood pressure decreased PT blood pressure decreased 374 CHRM4 activation 10047513 Vision blurred PT blurred vision 375 CHRM4 activation 10047853 Waxy flexibility PT catalepsy 376 CHRM4 activation 10016256 Fatigue PT exhaustion 377 CHRM4 activation 10062654 Foaming at mouth PT frothing 378 CHRM4 activation 10019301 Heart rate decreased PT heart rate decreased 379 CHRM4 activation 10022998 Irritability PT irritability 380 CHRM4 activation 10023644 Lacrimation increased PT lacrimation 381 CHRM4 activation 10028334 Muscle spasms PT muscle cramps 382 CHRM4 activation 10015995 Eyelid ptosis PT ptosis 383 CHRM4 activation 10027646 Miosis PT pupil diameter decreased 384 CHRM4 activation 10039424 Salivary hypersecretion PT salivation increased 385 CHRM4 activation 10020642 Hyperhidrosis PT sweating 386 CHRM5 activation 10039424 Salivary hypersecretion PT salivation increased 387 CHRNA4 activation 10013654 Drug abuse PT abuse potential 388 CHRNA4 activation 10053469 Analgesic therapy PT analgesia 389 CHRNA4 activation 10019303 Heart rate increased PT heart rate increased 390 CHRNA4 activation 10028813 Nausea PT nausea 391 CHRNA4 activation 10033557 Palpitations PT palpitations 392 CHRNA4 activation 10033799 Paralysis PT paralysis 393 CHRNA4 inhibition 10002974 Apnoea PT apnoea 394 CHRNA4 inhibition 10005734 Blood pressure decreased PT blood pressure decreased 395 CHRNA4 inhibition 10010774 Constipation PT constipation 396 CHRNA4 inhibition 10019301 Heart rate decreased PT heart rate decreased 397 CHRNA4 inhibition 10021118 Hypotonia PT muscle relaxation 398 CNR1 activation 10002855 Anxiety PT anxiety 399 CNR1 activation 10005734 Blood pressure decreased PT blood pressure decreased 400 CNR1 activation 10005910 Body temperature decreased PT body temperature decreased 401 CNR1 activation 10047853 Waxy flexibility PT catalepsy 402 CNR1 activation 10013573 Dizziness PT dizziness 404 CNR1 activation 10041349 Somnolence PT drowsiness 405 CNR1 activation 10012335 Dependence PT drug abuse/dependence 406 CNR1 activation 10013654 Drug abuse PT drug abuse/dependence 406 CNR1 activation 10013954 Dysphoria PT dysphoria 407 CNR1 activation 10020710 Hyperphagia PT eating increased 408 CNR1 activation 10021654 Increased appetite PT eating increased 408 CNR1 activation 10015535 Euphoric mood PT euphoria 409 CNR1 activation 10019063 Hallucination PT hallucinations 410 CNR1 activation 10019211 Headache PT headache 411 CNR1 activation 10019301 Heart rate decreased PT heart rate decreased 412 CNR1 activation 10021113 Hypothermia PT hypothermia 413 CNR1 activation 10011953 Decreased activity PT locomotor activity decreased 414 CNR1 activation 10061296 Motor dysfunction PT locomotor activity decreased 414 CNR1 activation 10027175 Memory impairment PT memory impairment 415 CNR1 activation 10029216 Nervousness PT nervousness 416 CNR1 activation 10053469 Analgesic therapy PT pain decreased 417 CNR1 activation 10013496 Disturbance in attention PT poor concentration 418 CNR1 inhibition 10039906 Seizure PT convulsions increased 419 CNR1 inhibition 10012378 Depression PT depression 420 CNR1 inhibition 10063743 Hypophagia PT eating decreased 421 CNR1 inhibition 10061428 Decreased appetite PT eating decreased 421 CNR1 inhibition 10047700 Vomiting PT emesis 422 CNR1 inhibition 10047895 Weight decreased PT weight loss increased 423 DRD1 activation 10058929 Disturbance in sexual arousal PT arousal increased 424 DRD1 activation 10024421 Libido increased PT arousal increased 424 DRD1 activation 10005734 Blood pressure decreased PT blood pressure decreased 425 DRD1 activation 10039906 Seizure PT convulsions 426 DRD1 activation 10013573 Dizziness PT dizziness 427 DRD1 activation 10012335 Dependence PT drug abuse/dependence 428 DRD1 activation 10013654 Drug abuse PT drug abuse/dependence 428 DRD1 activation 10013916 Dyskinesia PT dyskinesia 429 DRD1 activation 10061406 Cardiac valve disease PT fibrotic valvular heart disease 430 DRD1 activation 10019211 Headache PT headache 431 DRD1 activation 10007554 Cardiac failure PT heart failure 432 DRD1 activation 10021097 Hypotension PT hypotension 433 DRD1 activation 10011953 Decreased activity PT locomotor activity decreased 434 DRD1 activation 10061296 Motor dysfunction PT locomotor activity decreased 434 DRD1 activation 10061296 Motor dysfunction PT locomotor activity increased 435 DRD1 activation 10037211 Psychomotor hyperactivity PT locomotor activity increased 435 DRD1 activation 10028813 Nausea PT nausea 436 DRD1 activation 10053643 Neurodegenerative disorder PT neurodegeneration 437 DRD1 activation 10061920 Psychotic disorder PT psychosis 438 DRD1 activation 10046672 Urine sodium increased PT urinary sodium excretion increased 439 DRD1 activation 10062226 Urine analysis abnormal PT urinary sodium excretion increased 439 DRD1 activation 10059896 Urine output increased PT urine excretion increased 440 DRD1 activation 10047141 Vasodilatation PT vascular relaxation 441 DRD1 inhibition 10002855 Anxiety PT anxiety 442 DRD1 inhibition 10005750 Blood pressure increased PT blood pressure increased 443 DRD1 inhibition 10047853 Waxy flexibility PT catalepsy 444 DRD1 inhibition 10010947 Coordination abnormal PT coordination disorders 446 DRD1 inhibition 10012378 Depression PT depression 447 DRD1 inhibition 10013916 Dyskinesia PT dyskinesia 448 DRD1 inhibition 10011953 Decreased activity PT locomotor activity decreased 449 DRD1 inhibition 10061296 Motor dysfunction PT locomotor activity decreased 449 DRD1 inhibition 10044565 Tremor PT parkinsonian symptoms (tremors) 450 DRD1 inhibition 10034010 Parkinsonism PT parkinsonism 451 DRD1 inhibition 10039626 Schizophrenia PT schizophrenia 452 DRD1 inhibition 10042458 Suicidal ideation PT suicidal intent 453 DRD2 activation 10005734 Blood pressure decreased PT blood pressure decreased 454 DRD2 activation 10005910 Body temperature decreased PT body temperature decreased 455 DRD2 activation 10010305 Confusional state PT confusion 456 DRD2 activation 10041349 Somnolence PT drowsiness 458 DRD2 activation 10012335 Dependence PT drug abuse/dependence 459 DRD2 activation 10013654 Drug abuse PT drug abuse/dependence 459 DRD2 activation 10042772 Syncope PT fainting 460 DRD2 activation 10061406 Cardiac valve disease PT fibrotic valvular heart disease 461 DRD2 activation 10074598 Intestinal transit time decreased PT gastrointestinal transit decreased 462 DRD2 activation 10010774 Constipation PT gastrointestinal transit decreased 462 DRD2 activation 10017944 Gastrointestinal disorder PT gastrointestinal transit decreased 462 DRD2 activation 10019063 Hallucination PT hallucinations 463 DRD2 activation 10007554 Cardiac failure PT heart failure 464 DRD2 activation 10019301 Heart rate decreased PT heart rate decreased 465 DRD2 activation 10011953 Decreased activity PT locomotor activity decreased 466 DRD2 activation 10061296 Motor dysfunction PT locomotor activity decreased 466 DRD2 activation 10061296 Motor dysfunction PT locomotor activity increased 467 DRD2 activation 10037211 Psychomotor hyperactivity PT locomotor activity increased 467 DRD2 activation 10053469 Analgesic therapy PT pain decreased 468 DRD2 activation 10021067 Hypopituitarism PT pituitary hormone secretion decreased 469 DRD2 activation 10042008 Stereotypy PT stereotypy 470 DRD2 activation 10046672 Urine sodium increased PT urinary sodium excretion increased 471 DRD2 activation 10062226 Urine analysis abnormal PT urinary sodium excretion increased 471 DRD2 activation 10047700 Vomiting PT vomiting 472 DRD2 inhibition 10005750 Blood pressure increased PT blood pressure increased 473 DRD2 inhibition 10047853 Waxy flexibility PT catalepsy 474 DRD2 inhibition 10039906 Seizure PT convulsions increased 475 DRD2 inhibition 10041349 Somnolence PT drowsiness 476 DRD2 inhibition 10052402 Gastrointestinal hypermotility PT gastrointestinal motility increased 477 DRD2 inhibition 10017944 Gastrointestinal disorder PT gastrointestinal motility increased 477 DRD2 inhibition 10012735 Diarrhoea PT gastrointestinal motility increased 477 DRD2 inhibition 10074218 Intestinal transit time increased PT gastrointestinal transit increased 478 DRD2 inhibition 10017944 Gastrointestinal disorder PT gastrointestinal transit increased 478 DRD2 inhibition 10012735 Diarrhoea PT gastrointestinal transit increased 478 DRD2 inhibition 10011953 Decreased activity PT locomotor activity decreased 479 DRD2 inhibition 10061296 Motor dysfunction PT locomotor activity decreased 479 DRD2 inhibition 10031127 Orthostatic hypotension PT orthostatic hypotension 480 DRD2 inhibition 10059896 Urine output increased PT urine excretion increased 481 EDNRA activation 10005296 Blood aldosterone increased PT aldosterone secretion increased 482 EDNRA activation 10005750 Blood pressure increased PT blood pressure increased 483 EDNRA activation 10006482 Bronchospasm PT bronchoconstriction 484 EDNRA activation 10007596 Cardiac output increased PT cardiac contractility increased 485 EDNRA activation 10005089 Blast cell proliferation PT cell proliferation 486 EDNRA activation 10061481 Renal injury PT glomerular & tubulointerstitial structural injury 487 EDNRA activation 10078933 Renal tubular injury PT glomerular & tubulointerstitial structural injury 487 EDNRA activation 10069339 Acute kidney injury PT glomerular & tubulointerstitial structural injury 487 EDNRA activation 10019301 Heart rate decreased PT heart rate decreased 488 EDNRA activation 10047139 Vasoconstriction PT might cause vasoconstriction 489 EDNRA activation 10033371 Pain PT pain increased 490 EDNRA activation 10020568 Hyperesthesia PT pain increased 490 EDNRA activation 10049773 Left ventricular hypertrophy PT pulmonary left ventricular hypertrophy 491 EDNRA inhibition 10066054 Dysmorphism PT abnormal face 492 EDNRA inhibition 10005734 Blood pressure decreased PT blood pressure decreased 493 EDNRA inhibition 10082206 "Cardiac disorders, signs and symptoms NEC" HG cardiac anomily 494 EDNRA inhibition 10009269 Cleft palate PT cleft palate 495 EDNRA inhibition 10021518 Impaired gastric emptying PT gastric emptying decreased 496 EDNRA inhibition 10019303 Heart rate increased PT heart rate increased 497 EDNRA inhibition 10074598 Intestinal transit time decreased PT intestinal transit decreased 498 EDNRA inhibition 10010774 Constipation PT intestinal transit decreased 498 EDNRA inhibition 10017944 Gastrointestinal disorder PT intestinal transit decreased 498 EDNRA inhibition 10005089 Blast cell proliferation PT osteoblast proliferation 499 EDNRA inhibition 10053469 Analgesic therapy PT pain decreased 500 EDNRA inhibition 10043275 Teratogenicity PT teratogenicity 501 EDNRA inhibition 10052645 Thymus hypoplasia PT thymic hypoplasia 502 EDNRA inhibition 10059895 Urine output decreased PT urine excretion decreased 503 EDNRB activation 10005734 Blood pressure decreased PT blood pressure decreased 504 EDNRB activation 10005750 Blood pressure increased PT blood pressure increased 505 EDNRB activation 10006482 Bronchospasm PT bronchoconstriction 506 EDNRB activation 10005089 Blast cell proliferation PT cell proliferation 507 EDNRB activation 10061481 Renal injury PT glomerular & tubulointerstitial structural injury 508 EDNRB activation 10078933 Renal tubular injury PT glomerular & tubulointerstitial structural injury 508 EDNRB activation 10069339 Acute kidney injury PT glomerular & tubulointerstitial structural injury 508 EDNRB activation 10019301 Heart rate decreased PT heart rate decreased 509 EDNRB activation 10019303 Heart rate increased PT heart rate increased 510 EDNRB activation 10049773 Left ventricular hypertrophy PT left ventricular hypertrophy 511 EDNRB activation 10035517 Platelet aggregation decreased PT platelet aggregation decreased 512 EDNRB activation 10005140 Bleeding time prolonged PT platelet aggregation decreased 512 EDNRB activation 10037400 Pulmonary hypertension PT pulmonary hypertension 513 EDNRB activation 10047139 Vasoconstriction PT vasoconstriction 514 EDNRB inhibition 10005750 Blood pressure increased PT blood pressure increased 515 EDNRB inhibition 10074180 Craniofacial deformity PT craniofacial abnormalities 516 EDNRB inhibition 10021518 Impaired gastric emptying PT gastric emptying decreased 517 EDNRB inhibition 10074598 Intestinal transit time decreased PT intestinal transit decreased 518 EDNRB inhibition 10010774 Constipation PT intestinal transit decreased 518 EDNRB inhibition 10017944 Gastrointestinal disorder PT intestinal transit decreased 518 EDNRB inhibition 10053469 Analgesic therapy PT pain decreased 519 EDNRB inhibition 10035518 Platelet aggregation increased PT platelet aggregation 520 EDNRB inhibition 10059895 Urine output decreased PT urine excretion decreased 521 EDNRB inhibition 10047141 Vasodilatation PT vasodilatation 522 GABRA1 activation 10002711 Anterograde amnesia PT anterograde amnesia 523 GABRA1 activation 10003591 Ataxia PT ataxia 526 GABRA1 activation 10005734 Blood pressure decreased PT blood pressure decreased 527 GABRA1 activation 10005910 Body temperature decreased PT body temperature decreased 528 GABRA1 activation 10007554 Cardiac failure PT cardiac contractility decreased 529 GABRA1 activation 10007596 Cardiac output increased PT cardiac output increased 530 GABRA1 activation 10012378 Depression PT depression 532 GABRA1 activation 10013573 Dizziness PT dizziness 533 GABRA1 activation 10012335 Dependence PT drug abuse/dependence 534 GABRA1 activation 10013654 Drug abuse PT drug abuse/dependence 534 GABRA1 activation 10020710 Hyperphagia PT eating increased 535 GABRA1 activation 10021654 Increased appetite PT eating increased 535 GABRA1 activation 10011953 Decreased activity PT locomotor activity decreased 536 GABRA1 activation 10061296 Motor dysfunction PT locomotor activity decreased 536 GABRA1 activation 10027175 Memory impairment PT memory decreased 537 GABRA1 activation 10021118 Hypotonia PT muscle relaxation 538 GABRA1 activation 10053469 Analgesic therapy PT pain decreased 539 GABRA1 activation 10038712 Respiratory rate increased PT respiratory rate increased 540 GABRA1 activation 10039897 Sedation PT sedation 541 GABRA1 activation 10041349 Somnolence PT sedation 541 GABRA1 activation 10020765 Hypersomnia PT sleep increased 542 GABRA1 inhibition 10039906 Seizure PT convulsions 543 GABRA1 inhibition 10022437 Insomnia PT sleep decreased 544 GHSR inhibition 10005574 Blood growth hormone increased PT gh release 545 GRIN1 activation 10005750 Blood pressure increased PT blood pressure increased 546 GRIN1 activation 10039906 Seizure PT convulsions 547 GRIN1 activation 10019301 Heart rate decreased PT heart rate decreased 548 GRIN1 activation 10019303 Heart rate increased PT heart rate increased 549 GRIN1 activation 10033371 Pain PT pain 550 GRIN1 inhibition 10003591 Ataxia PT ataxia 551 GRIN1 inhibition 10005750 Blood pressure increased PT blood pressure increased 552 GRIN1 inhibition 10012218 Delirium PT delirium 554 GRIN1 inhibition 10013395 Disorientation PT disoriented behaviour 555 GRIN1 inhibition 10013573 Dizziness PT dizziness 556 GRIN1 inhibition 10012335 Dependence PT drug abuse/dependence 557 GRIN1 inhibition 10013654 Drug abuse PT drug abuse/dependence 557 GRIN1 inhibition 10019063 Hallucination PT hallucinations 558 GRIN1 inhibition 10019303 Heart rate increased PT heart rate increased 559 GRIN1 inhibition 10061108 Disturbance in social behaviour PT impaired social interactions 560 GRIN1 inhibition 10061296 Motor dysfunction PT locomotor activity increased 561 GRIN1 inhibition 10037211 Psychomotor hyperactivity PT locomotor activity increased 561 GRIN1 inhibition 10027175 Memory impairment PT memory decreased 562 GRIN1 inhibition 10053643 Neurodegenerative disorder PT neurodegeneration 563 GRIN1 inhibition 10029350 Neurotoxicity PT neurotoxicity 564 GRIN1 inhibition 10053469 Analgesic therapy PT pain decreased 565 GRIN1 inhibition 10061920 Psychotic disorder PT psychosis 566 GRIN1 inhibition 10042008 Stereotypy PT stereotypy 567 HRH1 activation 10000081 Abdominal pain PT abdominal cramps 568 HRH1 activation 10020751 Hypersensitivity PT allergic responses of flare 569 HRH1 activation 10046735 Urticaria PT allergic responses of wheal 570 HRH1 activation 10005734 Blood pressure decreased PT blood pressure decreased 571 HRH1 activation 10006482 Bronchospasm PT bronchoconstriction 572 HRH1 activation 10012735 Diarrhoea PT diarrhea 574 HRH1 activation 10036067 Polydipsia PT drinking increased 575 HRH1 activation 10042682 Swelling face PT facial swelling 576 HRH1 activation 10016825 Flushing PT flushing 577 HRH1 activation 10061218 Inflammation PT inflammation 578 HRH1 activation 10033371 Pain PT pain increased 579 HRH1 activation 10020568 Hyperesthesia PT pain increased 579 HRH1 activation 10039737 Scratch PT scratching 580 HRH1 activation 10037087 Pruritus PT scratching 580 HRH1 activation 10037844 Rash PT skin rash 581 HRH1 activation 10020642 Hyperhidrosis PT sweating 582 HRH1 activation 10042727 Swollen tongue PT tongue swelling 583 HRH1 inhibition 10005734 Blood pressure decreased PT blood pressure decreased 585 HRH1 inhibition 10005750 Blood pressure increased PT blood pressure increased 586 HRH1 inhibition 10047899 Weight increased PT body weight increased 587 HRH1 inhibition 10003119 Arrhythmia PT cardiac arrhythmia 588 HRH1 inhibition 10039906 Seizure PT convulsions increased 589 HRH1 inhibition 10074598 Intestinal transit time decreased PT gastrointestinal transit decreased 590 HRH1 inhibition 10010774 Constipation PT gastrointestinal transit decreased 590 HRH1 inhibition 10017944 Gastrointestinal disorder PT gastrointestinal transit decreased 590 HRH1 inhibition 10019303 Heart rate increased PT heart rate increased 591 HRH1 inhibition 10061296 Motor dysfunction PT locomotor activity increased 593 HRH1 inhibition 10037211 Psychomotor hyperactivity PT locomotor activity increased 593 HRH1 inhibition 10053469 Analgesic therapy PT pain decreased 594 HRH1 inhibition 10014387 Electrocardiogram QT prolonged PT qtc interval increased 595 HRH1 inhibition 10039897 Sedation PT sedation 596 HRH1 inhibition 10041349 Somnolence PT sedation 596 HRH1 inhibition 10020765 Hypersomnia PT sleep increased 597 HRH2 activation 10005734 Blood pressure decreased PT blood pressure decreased 598 HRH2 activation 10036067 Polydipsia HT drinking increased 599 HRH2 activation 10047700 Vomiting PT emesis 600 HRH2 activation 10060041 Gastric pH decreased PT gastric acid secretion increased 601 HRH2 activation 10020601 Hyperchlorhydria PT gastric acid secretion increased 601 HRH2 activation 10019303 Heart rate increased PT heart rate increased 603 HRH2 activation 10061218 Inflammation PT inflammation 604 HRH2 activation 10062991 Positive cardiac inotropic effect PT positive inotropy 605 HRH2 inhibition 10063743 Hypophagia PT eating decreased 606 HRH2 inhibition 10061428 Decreased appetite PT eating decreased 606 HRH2 inhibition 10060040 Gastric pH increased PT gastric acid secretion decreased 607 HRH2 inhibition 10000451 Achlorhydria PT gastric acid secretion decreased 607 HRH2 inhibition 10021518 Impaired gastric emptying PT gastric emptying decreased 608 HRH2 inhibition 10053469 Analgesic therapy PT pain decreased 610 HRH3 activation 10047141 Vasodilatation PT vasodilatation 611 HRH3 inhibition 10039897 Sedation PT causes sedation 612 HRH3 inhibition 10041349 Somnolence PT causes sedation 612 HRH3 inhibition 10052105 Gastrointestinal hypomotility PT gastrointestinal motility decreased 613 HRH3 inhibition 10010774 Constipation PT gastrointestinal motility decreased 613 HRH3 inhibition 10017944 Gastrointestinal disorder PT gastrointestinal motility decreased 613 HRH3 inhibition 10027175 Memory impairment PT memory decreased 614 HRH3 inhibition 10019301 Heart rate decreased PT negative chronotropy 615 HTR1A activation 10005453 Blood corticotrophin increased PT adrenocoticotropic hormone increased 616 HTR1A activation 10005734 Blood pressure decreased PT blood pressure decreased 619 HTR1A activation 10005910 Body temperature decreased PT body temperature decreased 620 HTR1A activation 10011207 Cortisol increased PT cortisol hormone secretion increased 621 HTR1A activation 10005574 Blood growth hormone increased PT growth hormone secretion increased 622 HTR1A activation 10019303 Heart rate increased PT heart rate increased 623 HTR1A activation 10011953 Decreased activity PT locomotor activity decreased 624 HTR1A activation 10061296 Motor dysfunction PT locomotor activity decreased 624 HTR1A activation 10061296 Motor dysfunction PT locomotor activity increased 625 HTR1A activation 10037211 Psychomotor hyperactivity PT locomotor activity increased 625 HTR1A activation 10027175 Memory impairment PT memory decreased 626 HTR1A activation 10053469 Analgesic therapy PT pain decreased 627 HTR1A activation 10027646 Miosis PT pupil diameter decreased 628 HTR1A activation 10028521 Mydriasis PT pupil diameter increased 629 HTR1A activation 10037841 Rapid eye movements sleep abnormal PT reduced rapid eye movement sleep 630 HTR1A activation 10022437 Insomnia PT sleep decreased 631 HTR1A activation 10020765 Hypersomnia PT sleep increased 632 HTR1A activation 10042008 Stereotypy PT stereotypy 633 HTR1A inhibition 10013573 Dizziness PT dizziness 635 HTR1A inhibition 10061296 Motor dysfunction PT locomotor activity increased 636 HTR1A inhibition 10037211 Psychomotor hyperactivity PT locomotor activity increased 636 HTR1A inhibition 10033775 Paresthesia PT paresthesia 638 HTR1A inhibition 10002855 Anxiety PT potentially anxiogenic 639 HTR1A inhibition 10022437 Insomnia PT sleep decreased 640 HTR1A inhibition 10047571 Visual impairment PT visual disturbances 641 HTR2A activation 10001497 Agitation PT agitation 642 HTR2A activation 10005750 Blood pressure increased PT blood pressure increased 643 HTR2A activation 10005911 Body temperature increased PT body temperature increased 644 HTR2A activation 10012335 Dependence PT drug abuse/dependence 645 HTR2A activation 10013654 Drug abuse PT drug abuse/dependence 645 HTR2A activation 10019063 Hallucination PT hallucinations 646 HTR2A activation 10019303 Heart rate increased PT heart rate increased 647 HTR2A activation 10020745 Hyperreflexia PT hyperreflexia 648 HTR2A activation 10048533 Hypervigilance PT hypervigilance 649 HTR2A activation 10027175 Memory impairment PT memory decreased 650 HTR2A activation 10028622 Myoclonus PT myoclonus 651 HTR2A activation 10033371 Pain PT pain increased 652 HTR2A activation 10020568 Hyperesthesia PT pain increased 652 HTR2A activation 10035518 Platelet aggregation increased PT platelet aggregation 653 HTR2A activation 10061920 Psychotic disorder PT psychosis 654 HTR2A activation 10028521 Mydriasis PT pupil diameter increased 655 HTR2A activation 10039626 Schizophrenia PT schizophrenia 656 HTR2A activation 10040108 Serotonin syndrome PT serotonin syndrome 657 HTR2A activation 10028293 Muscle contractions involuntary PT smooth muscle contraction 658 HTR2A activation 10042008 Stereotypy PT stereotypy 659 HTR2A activation 10020642 Hyperhidrosis PT sweating 660 HTR2A inhibition 10005910 Body temperature decreased PT body temperature decreased 661 HTR2A inhibition 10053469 Analgesic therapy PT pain decreased 663 HTR2A inhibition 10035517 Platelet aggregation decreased PT platelet aggregation decreased 664 HTR2A inhibition 10005140 Bleeding time prolonged PT platelet aggregation decreased 664 HTR2A inhibition 10020765 Hypersomnia PT sleep increased 665 HTR2B activation 10061406 Cardiac valve disease PT cardiac valvulopathy 667 HTR2B activation 10033371 Pain PT pain increased 668 HTR2B activation 10020568 Hyperesthesia PT pain increased 668 HTR2B activation 10037400 Pulmonary hypertension PT pulmonary hypertension 669 HTR2B inhibition 10027661 Cardiovascular disorders congenital NEC HT cardiovascular malformations 670 HTR2B inhibition 10074598 Intestinal transit time decreased PT gastrointestinal transit decreased 671 HTR2B inhibition 10010774 Constipation PT gastrointestinal transit decreased 671 HTR2B inhibition 10017944 Gastrointestinal disorder PT gastrointestinal transit decreased 671 HTR2B inhibition 10053469 Analgesic therapy PT pain decreased 672 HTR2B inhibition 10007543 Cardiac disorders NEC HT possible cardiac effects 673 HTR2C activation 10013916 Dyskinesia PT abnormal mouth movements 674 HTR2C activation 10002855 Anxiety PT anxiety increased 675 HTR2C activation 10039906 Seizure PT convulsions increased 676 HTR2C activation 10063743 Hypophagia PT eating decreased 677 HTR2C activation 10061428 Decreased appetite PT eating decreased 677 HTR2C activation 10011953 Decreased activity PT locomotor activity decreased 678 HTR2C activation 10061296 Motor dysfunction PT locomotor activity decreased 678 HTR2C activation 10027175 Memory impairment PT memory decreased 679 HTR2C activation 10015120 Erection increased PT penile erection 680 HTR2C inhibition 10012335 Dependence PT drug abuse/dependence 683 HTR2C inhibition 10013654 Drug abuse PT drug abuse/dependence 683 HTR3A activation 10002974 Apnoea PT apnea 685 HTR3A activation 10005750 Blood pressure increased PT blood pressure increased 686 HTR3A activation 10012335 Dependence PT drug abuse/dependence 687 HTR3A activation 10013654 Drug abuse PT drug abuse/dependence 687 HTR3A activation 10074218 Intestinal transit time increased PT gastrointestinal transit increased 689 HTR3A activation 10017944 Gastrointestinal disorder PT gastrointestinal transit increased 689 HTR3A activation 10012735 Diarrhoea PT gastrointestinal transit increased 689 HTR3A activation 10019303 Heart rate increased PT heart rate increased 690 HTR3A activation 10020635 Hyperglycemia PT hyperglycaemia 691 HTR3A activation 10027175 Memory impairment PT memory decreased 692 HTR3A activation 10047700 Vomiting PT vomiting 693 HTR3A inhibition 10000060 Abdominal distension PT abdominal distension 694 HTR3A inhibition 10010774 Constipation PT constipation 696 HTR3A inhibition 10013573 Dizziness PT dizziness 697 HTR3A inhibition 10074598 Intestinal transit time decreased PT gastrointestinal transit decreased 698 HTR3A inhibition 10010774 Constipation PT gastrointestinal transit decreased 698 HTR3A inhibition 10017944 Gastrointestinal disorder PT gastrointestinal transit decreased 698 HTR3A inhibition 10016101 Feces hard PT hard stool 699 HTR3A inhibition 10009895 Colitis ischemic PT ischemic colitis 701 HTR3A inhibition 10053469 Analgesic therapy PT pain decreased 703 HTR7 activation 10005910 Body temperature decreased PT body temperature decreased 704 HTR7 activation 10053469 Analgesic therapy PT pain decreased 707 HTR7 activation 10033371 Pain PT pain increased 708 HTR7 activation 10020568 Hyperesthesia PT pain increased 708 HTR7 activation 10022437 Insomnia PT sleep decreased 709 HTR7 inhibition 10027175 Memory impairment PT memory decreased 711 HTR7 inhibition 10053469 Analgesic therapy PT pain decreased 713 HTR7 inhibition 10022437 Insomnia PT sleep decreased 714 KCNH2 inhibition 10014387 Electrocardiogram QT prolonged PT prolongation of qt interval of ecg 715 MAOA inhibition 10013710 Drug interaction PT blood pressure when combined with amines such as tyramine increased 718 MAOA inhibition 10013573 Dizziness PT dizziness 719 MAOA inhibition 10013710 Drug interaction PT drug-drug interactions 720 MAOA inhibition 10016256 Fatigue PT fatigue 721 MAOA inhibition 10028813 Nausea PT nausea 722 MAOA inhibition 10040984 Sleep disorder PT sleep disturbances 723 MAOA inhibition 10044565 Tremor PT tremors 724 MAOA inhibition 10003549 Asthenia PT weakness 725 NPY1R activation 10061218 Inflammation PT inflammation increased 727 NPY1R activation 10053469 Analgesic therapy PT pain decreased 728 NPY1R inhibition 10063743 Hypophagia PT eating decreased 729 NPY1R inhibition 10061428 Decreased appetite PT eating decreased 729 NPY1R unknown 10060040 Gastric pH increased PT acid secretion decreased 730 NPY1R unknown 10000451 Achlorhydria PT acid secretion decreased 730 NPY1R unknown 10002855 Anxiety PT anxiogenic 731 NPY1R unknown 10047139 Vasoconstriction PT causes vasoconstriction (venous) 732 NPY1R unknown 10021518 Impaired gastric emptying PT gastric emptying decreased 733 NPY1R unknown 10052105 Gastrointestinal hypomotility PT gut motility decreased 734 NPY1R unknown 10010774 Constipation PT gut motility decreased 734 NPY1R unknown 10017944 Gastrointestinal disorder PT gut motility decreased 734 NPY1R unknown 10079281 Pancreatic failure PT pancreatic exocrine secretions decreased 735 NR3C1 activation 10003119 Arrhythmia PT arrhythmia 736 NR3C1 activation 10005557 Blood glucose increased PT blood glucose increased 737 NR3C1 activation 10005750 Blood pressure increased PT blood pressure increased 738 NR3C1 activation 10047899 Weight increased PT body weight increased 739 NR3C1 activation 10018304 Glaucoma PT glaucoma 740 NR3C1 activation 10020635 Hyperglycemia PT hyperglycaemia 741 NR3C1 activation 10062016 Immunosuppression PT immunosuppression 742 NR3C1 activation 10022489 Insulin resistance PT insulin resistance 744 NR3C1 activation 10048474 Fat redistribution PT lipid redistribution 745 NR3C1 activation 10028289 Muscle atrophy PT muscle mass decreased 747 NR3C1 activation 10031282 Osteoporosis PT osteoporosis 748 NR3C1 activation 10053469 Analgesic therapy PT pain decreased 749 NR3C1 activation 10046672 Urine sodium increased PT urinary sodium excretion increased 750 NR3C1 activation 10062226 Urine analysis abnormal PT urinary sodium excretion increased 750 NR3C1 activation 10021519 Impaired healing PT wound repair decreased 751 NR3C1 inhibition 10005724 Blood potassium decreased PT blood potassium decreased 752 NR3C1 inhibition 10030095 Oedema PT edema 753 NR3C1 inhibition 10056432 Endometrial thickening PT endometrial thickening 754 NR3C1 inhibition 10016256 Fatigue PT fatigue 755 NR3C1 inhibition 10020993 Hypoglycemia PT hypoglycaemia 756 NR3C1 inhibition 10061218 Inflammation PT inflammation increased 757 NR3C1 inhibition 10027175 Memory impairment PT memory decreased 758 NR3C1 inhibition 10053469 Analgesic therapy PT pain decreased 759 NR3C1 inhibition 10033371 Pain PT pain increased 760 NR3C1 inhibition 10020568 Hyperesthesia PT pain increased 760 OPRD1 activation 10005910 Body temperature decreased PT body temperature decreased 761 OPRD1 activation 10007543 Cardiac disorders NEC HT cardiovascular effects 762 OPRD1 activation 10039906 Seizure PT convulsions 763 OPRD1 activation 10013954 Dysphoria PT dysphoria 764 OPRD1 activation 10015535 Euphoric mood PT euphoria 765 OPRD1 activation 10074598 Intestinal transit time decreased PT gastrointestinal transit decreased 766 OPRD1 activation 10010774 Constipation PT gastrointestinal transit decreased 766 OPRD1 activation 10017944 Gastrointestinal disorder PT gastrointestinal transit decreased 766 OPRD1 activation 10061296 Motor dysfunction PT locomotor activity increased 767 OPRD1 activation 10037211 Psychomotor hyperactivity PT locomotor activity increased 767 OPRD1 activation 10053469 Analgesic therapy PT pain decreased 768 OPRD1 activation 10061920 Psychotic disorder PT psychomimetic effects 769 OPRD1 activation 10038678 Respiratory depression PT respiratory depression 770 OPRD1 inhibition 10002855 Anxiety PT anxiety increased 771 OPRD1 inhibition 10005750 Blood pressure increased PT blood pressure increased 772 OPRD1 inhibition 10007596 Cardiac output increased PT cardiac contractility increased 773 OPRD1 inhibition 10033371 Pain PT pain increased 774 OPRD1 inhibition 10020568 Hyperesthesia PT pain increased 774 OPRK1 activation 10002855 Anxiety PT anxiety increased 775 OPRK1 activation 10005734 Blood pressure decreased PT blood pressure decreased 776 OPRK1 activation 10005910 Body temperature decreased PT body temperature decreased 777 OPRK1 activation 10007554 Cardiac failure PT cardiac contractility decreased 778 OPRK1 activation 10010305 Confusional state PT confusion 779 OPRK1 activation 10013573 Dizziness PT dizziness 781 OPRK1 activation 10056291 Fluid intake reduced PT drinking decreased 782 OPRK1 activation 10036067 Polydipsia HT drinking increased 783 OPRK1 activation 10012335 Dependence PT drug abuse/dependence 784 OPRK1 activation 10013654 Drug abuse PT drug abuse/dependence 784 OPRK1 activation 10013954 Dysphoria PT dysphoria 785 OPRK1 activation 10063743 Hypophagia PT eating decreased 786 OPRK1 activation 10061428 Decreased appetite PT eating decreased 786 OPRK1 activation 10020710 Hyperphagia PT eating increased 787 OPRK1 activation 10021654 Increased appetite PT eating increased 787 OPRK1 activation 10052105 Gastrointestinal hypomotility PT gastrointestinal motility decreased 788 OPRK1 activation 10010774 Constipation PT gastrointestinal motility decreased 788 OPRK1 activation 10017944 Gastrointestinal disorder PT gastrointestinal motility decreased 788 OPRK1 activation 10074598 Intestinal transit time decreased PT gastrointestinal transit decreased 789 OPRK1 activation 10010774 Constipation PT gastrointestinal transit decreased 789 OPRK1 activation 10017944 Gastrointestinal disorder PT gastrointestinal transit decreased 789 OPRK1 activation 10019063 Hallucination PT hallucinations 790 OPRK1 activation 10019301 Heart rate decreased PT heart rate decreased 791 OPRK1 activation 10019303 Heart rate increased PT heart rate increased 792 OPRK1 activation 10011953 Decreased activity PT locomotor activity decreased 794 OPRK1 activation 10061296 Motor dysfunction PT locomotor activity decreased 794 OPRK1 activation 10053469 Analgesic therapy PT pain decreased 795 OPRK1 activation 10039897 Sedation PT sedation 796 OPRK1 activation 10041349 Somnolence PT sedation 796 OPRK1 activation 10043071 Tachycardia PT tachycardia 797 OPRK1 activation 10059896 Urine output increased PT urine excretion increased 798 OPRK1 inhibition 10039906 Seizure PT convulsions increased 800 OPRK1 inhibition 10056291 Fluid intake reduced PT drinking decreased 801 OPRK1 inhibition 10063743 Hypophagia PT eating decreased 802 OPRK1 inhibition 10061428 Decreased appetite PT eating decreased 802 OPRK1 inhibition 10033371 Pain PT pain increased 803 OPRK1 inhibition 10020568 Hyperesthesia PT pain increased 803 OPRM1 activation 10005557 Blood glucose increased PT blood glucose increased 805 OPRM1 activation 10005614 Blood insulin increased PT blood insulin increased 806 OPRM1 activation 10005734 Blood pressure decreased PT blood pressure decreased 807 OPRM1 activation 10005750 Blood pressure increased PT blood pressure increased 808 OPRM1 activation 10005910 Body temperature decreased PT body temperature decreased 809 OPRM1 activation 10005911 Body temperature increased PT body temperature increased 810 OPRM1 activation 10007595 Cardiac output decreased PT cardiac output decreased 811 OPRM1 activation 10039906 Seizure PT convulsions increased 813 OPRM1 activation 10012335 Dependence PT drug abuse/dependence 814 OPRM1 activation 10013654 Drug abuse PT drug abuse/dependence 814 OPRM1 activation 10060040 Gastric pH increased PT gastric acid secretion decreased 815 OPRM1 activation 10000451 Achlorhydria PT gastric acid secretion decreased 815 OPRM1 activation 10021518 Impaired gastric emptying PT gastric emptying decreased 816 OPRM1 activation 10052105 Gastrointestinal hypomotility PT gastrointestinal motility decreased 817 OPRM1 activation 10010774 Constipation PT gastrointestinal motility decreased 817 OPRM1 activation 10017944 Gastrointestinal disorder PT gastrointestinal motility decreased 817 OPRM1 activation 10074598 Intestinal transit time decreased PT gastrointestinal transit decreased 818 OPRM1 activation 10010774 Constipation PT gastrointestinal transit decreased 818 OPRM1 activation 10017944 Gastrointestinal disorder PT gastrointestinal transit decreased 818 OPRM1 activation 10019301 Heart rate decreased PT heart rate decreased 819 OPRM1 activation 10021113 Hypothermia PT hypothermia 820 OPRM1 activation 10027175 Memory impairment PT memory decreased 821 OPRM1 activation 10053469 Analgesic therapy PT pain decreased 823 OPRM1 activation 10027646 Miosis PT pupil diameter decreased 824 OPRM1 activation 10028521 Mydriasis PT pupil diameter increased 825 OPRM1 activation 10038678 Respiratory depression PT respiratory depression 826 OPRM1 activation 10038710 Respiratory rate decreased PT respiratory rate decreased 827 OPRM1 activation 10039737 Scratch PT scratching 828 OPRM1 activation 10037087 Pruritus PT scratching 828 OPRM1 activation 10039897 Sedation PT sedation 829 OPRM1 activation 10041349 Somnolence PT sedation 829 OPRM1 activation 10046672 Urine sodium increased PT urinary sodium excretion increased 830 OPRM1 activation 10062226 Urine analysis abnormal PT urinary sodium excretion increased 830 OPRM1 activation 10059896 Urine output increased PT urine excretion increased 831 OPRM1 inhibition 10005750 Blood pressure increased PT blood pressure increased 832 OPRM1 inhibition 10039906 Seizure PT convulsions increased 834 OPRM1 inhibition 10013946 Dyspepsia PT dyspepsia 835 OPRM1 inhibition 10016766 Flatulence PT gas 836 OPRM1 inhibition 10021518 Impaired gastric emptying PT gastric emptying decreased 837 OPRM1 inhibition 10052402 Gastrointestinal hypermotility PT gastrointestinal motility increased 838 OPRM1 inhibition 10017944 Gastrointestinal disorder PT gastrointestinal motility increased 838 OPRM1 inhibition 10012735 Diarrhoea PT gastrointestinal motility increased 838 OPRM1 inhibition 10074218 Intestinal transit time increased PT gastrointestinal transit increased 839 OPRM1 inhibition 10017944 Gastrointestinal disorder PT gastrointestinal transit increased 839 OPRM1 inhibition 10012735 Diarrhoea PT gastrointestinal transit increased 839 OPRM1 inhibition 10019303 Heart rate increased PT heart rate increased 840 OPRM1 inhibition 10033371 Pain PT pain increased 841 OPRM1 inhibition 10020568 Hyperesthesia PT pain increased 841 PDE3A inhibition 10005734 Blood pressure decreased PT blood pressure decreased 842 PDE3A inhibition 10007596 Cardiac output increased PT cardiac contractility increased 843 PDE3A inhibition 10021926 Infertility PT female fertility decreased 844 PDE3A inhibition 10019303 Heart rate increased PT heart rate increased 845 PDE3A inhibition 10035517 Platelet aggregation decreased PT platelet aggregation decreased 846 PDE3A inhibition 10005140 Bleeding time prolonged PT platelet aggregation decreased 846 PDE3A inhibition 10035528 Platelet count decreased PT platelets decreased 847 PDE3A inhibition 10047281 Ventricular arrhythmia PT ventricular arrhythmia 848 PDE4D inhibition 10003230 Arteritis PT arteritis 849 PDE4D inhibition 10047700 Vomiting PT emesis 851 PDE4D inhibition 10061381 Thymus disorder PT possible thymus atrophy 853 PDE4D inhibition 10047115 Vasculitis PT vasculitis 854 PPARG activation 10005555 Blood glucose decreased PT blood glucose decreased 855 PPARG activation 10047899 Weight increased PT body weight increased 856 PPARG activation 10007554 Cardiac failure PT heart failure 857 PPARG activation 10047690 Volume blood increased PT plasma volume increased 860 PPARG activation 10035517 Platelet aggregation decreased PT platelet aggregation decreased 861 PPARG activation 10005140 Bleeding time prolonged PT platelet aggregation decreased 861 PPARG activation 10046671 Urine sodium decreased PT urinary sodium excretion decreased 862 PPARG activation 10062226 Urine analysis abnormal PT urinary sodium excretion decreased 862 PPARG activation 10059895 Urine output decreased PT urine excretion decreased 863 PPARG activation 10016807 Fluid retention PT water retention increased 864 PPARG inhibition 10061218 Inflammation PT inflammation increased 865 PTGS1 inhibition 10013946 Dyspepsia PT dyspepsia 866 PTGS1 inhibition 10017788 Gastric hemorrhage PT gastric bleeding 867 PTGS1 inhibition 10037394 Pulmonary hemorrhage PT pulmonary bleeding 868 PTGS1 inhibition 10062237 Renal impairment PT renal dysfunction 869 PTGS2 inhibition 10003210 Arteriosclerosis PT atheroschlerosis 870 PTGS2 inhibition 10003178 Arterial thrombosis PT atherothrombosis 871 PTGS2 inhibition 10005750 Blood pressure increased PT blood pressure increased 872 PTGS2 inhibition 10028596 Myocardial infarction PT heart attack 873 PTGS2 inhibition 10061256 Ischemic stroke PT ischemic stroke 875 PTGS2 inhibition 10053469 Analgesic therapy PT pain decreased 877 PTGS2 inhibition 10043607 Thrombosis PT thrombosis 878 PTGS2 inhibition 10046662 Urine potassium decreased PT urinary potassium excretion decreased 879 PTGS2 inhibition 10046671 Urine sodium decreased PT urinary sodium excretion decreased 880 PTGS2 inhibition 10062226 Urine analysis abnormal PT urinary sodium excretion decreased 880 SCN5A activation 10003119 Arrhythmia PT cardiac arrhythmia 881 SCN5A activation 10039906 Seizure PT "convulsions, convulsions increased" 882 SCN5A activation 10013968 Dyspnoea PT dyspnea 883 SCN5A activation 10019303 Heart rate increased PT heart rate increased 884 SCN5A activation 10011953 Decreased activity PT locomotor activity decreased 885 SCN5A activation 10061296 Motor dysfunction PT locomotor activity decreased 885 SCN5A inhibition 10001497 Agitation PT agitation 886 SCN5A inhibition 10005734 Blood pressure decreased PT blood pressure decreased 887 SCN5A inhibition 10003119 Arrhythmia PT cardiac arrhythmia 888 SCN5A inhibition 10000032 Cardiac conduction disorders HT cardiac conduction decreased 889 SCN5A inhibition 10007554 Cardiac failure PT cardiac contractility decreased 890 SCN5A inhibition 10010071 Coma PT coma 891 SCN5A inhibition 10039906 Seizure PT convulsions increased 893 SCN5A inhibition 10074598 Intestinal transit time decreased PT gastrointestinal transit decreased 894 SCN5A inhibition 10010774 Constipation PT gastrointestinal transit decreased 894 SCN5A inhibition 10017944 Gastrointestinal disorder PT gastrointestinal transit decreased 894 SCN5A inhibition 10019301 Heart rate decreased PT heart rate decreased 895 SCN5A inhibition 10019303 Heart rate increased PT heart rate increased 896 SCN5A inhibition 10053469 Analgesic therapy PT pain decreased 897 SCN5A inhibition 10028521 Mydriasis PT pupil diameter increased 898 SCN5A inhibition 10014380 Electrocardiogram QRS complex prolonged PT qrs complex increased 899 SCN5A inhibition 10038710 Respiratory rate decreased PT respiratory rate decreased 900 SCN5A inhibition 10021013 Hypohidrosis PT sweating decreased 901 SCN5A inhibition 10059895 Urine output decreased PT urine excretion decreased 902 SLC6A2 inhibition 10005750 Blood pressure increased PT blood pressure increased 903 SLC6A2 inhibition 10047513 Vision blurred PT blurred vision 904 SLC6A2 inhibition 10007596 Cardiac output increased PT cardiac output increased 905 SLC6A2 inhibition 10010774 Constipation PT constipation 906 SLC6A2 inhibition 10012335 Dependence PT drug abuse/dependence 907 SLC6A2 inhibition 10013654 Drug abuse PT drug abuse/dependence 907 SLC6A2 inhibition 10063743 Hypophagia PT eating decreased 908 SLC6A2 inhibition 10061428 Decreased appetite PT eating decreased 908 SLC6A2 inhibition 10019303 Heart rate increased PT heart rate increased 909 SLC6A2 inhibition 10011953 Decreased activity PT locomotor activity decreased 910 SLC6A2 inhibition 10061296 Motor dysfunction PT locomotor activity decreased 910 SLC6A2 inhibition 10061296 Motor dysfunction PT locomotor activity increased 911 SLC6A2 inhibition 10037211 Psychomotor hyperactivity PT locomotor activity increased 911 SLC6A2 inhibition 10031127 Orthostatic hypotension PT orthostatic hypotension 912 SLC6A2 inhibition 10053469 Analgesic therapy PT pain decreased 913 SLC6A2 inhibition 10037532 Pupillary reflex impaired PT pupillary reflex decreased 914 SLC6A2 inhibition 10014387 Electrocardiogram QT prolonged PT qtc interval increased 915 SLC6A2 inhibition 10003068 Aptyalism PT salivation decreased 916 SLC6A2 inhibition 10022437 Insomnia PT sleep decreased 917 SLC6A2 inhibition 10020642 Hyperhidrosis PT sweating 918 SLC6A2 inhibition 10046542 Urinary hesitation PT urinary hesitancy 919 SLC6A2 inhibition 10047295 Ventricular hypertrophy PT ventricular hypertrophy 920 SLC6A3 activation 10010947 Coordination abnormal PT coordination decreased 921 SLC6A3 activation 10003549 Asthenia PT motor strength decreased 922 SLC6A3 activation 10016256 Fatigue PT motor strength decreased 922 SLC6A3 inhibition 10000496 Acne PT acne 923 SLC6A3 inhibition 10039906 Seizure PT convulsions 924 SLC6A3 inhibition 10012378 Depression PT depression 925 SLC6A3 inhibition 10012335 Dependence PT drug abuse/dependence 926 SLC6A3 inhibition 10013654 Drug abuse PT drug abuse/dependence 926 SLC6A3 inhibition 10013916 Dyskinesia PT dyskinesia 927 SLC6A3 inhibition 10013983 Dystonia PT dystonia 928 SLC6A3 inhibition 10061296 Motor dysfunction PT locomotor activity increased 929 SLC6A3 inhibition 10037211 Psychomotor hyperactivity PT locomotor activity increased 929 SLC6A3 inhibition 10034010 Parkinsonism PT parkinsonism 930 SLC6A3 inhibition 10061920 Psychotic disorder PT psychostimulation 931 SLC6A3 inhibition 10042008 Stereotypy PT stereotypy 932 SLC6A4 activation 10037400 Pulmonary hypertension PT pulmonary hypertension 933 SLC6A4 inhibition 10002855 Anxiety PT anxiety increased 935 SLC6A4 inhibition 10061428 Decreased appetite PT appetite decreased 936 SLC6A4 inhibition 10047895 Weight decreased PT body weight decreased 937 SLC6A4 inhibition 10010774 Constipation PT diarrhea/constipation 938 SLC6A4 inhibition 10012735 Diarrhoea PT diarrhea/constipation 938 SLC6A4 inhibition 10013573 Dizziness PT dizziness 939 SLC6A4 inhibition 10013781 Dry mouth PT dry mouth 940 SLC6A4 inhibition 10063743 Hypophagia PT eating decreased 941 SLC6A4 inhibition 10061428 Decreased appetite PT eating decreased 941 SLC6A4 inhibition 10052402 Gastrointestinal hypermotility PT gastrointestinal motility increased 942 SLC6A4 inhibition 10017944 Gastrointestinal disorder PT gastrointestinal motility increased 942 SLC6A4 inhibition 10012735 Diarrhoea PT gastrointestinal motility increased 942 SLC6A4 inhibition 10019211 Headache PT headache 943 SLC6A4 inhibition 10011953 Decreased activity PT locomotor activity decreased 944 SLC6A4 inhibition 10061296 Motor dysfunction PT locomotor activity decreased 944 SLC6A4 inhibition 10061296 Motor dysfunction PT locomotor activity increased 945 SLC6A4 inhibition 10037211 Psychomotor hyperactivity PT locomotor activity increased 945 SLC6A4 inhibition 10028813 Nausea PT nausea 946 SLC6A4 inhibition 10038557 Renin decreased PT plasma renin decreased 947 SLC6A4 inhibition 10035517 Platelet aggregation decreased PT platelet aggregation decreased 948 SLC6A4 inhibition 10005140 Bleeding time prolonged PT platelet aggregation decreased 948 SLC6A4 inhibition 10040477 Sexual dysfunction PT sexual dysfunction 949 SLC6A4 inhibition 10022437 Insomnia PT sleep decreased 950 SLC6A4 inhibition 10044565 Tremor PT tremor 951 SLC6A4 inhibition 10074598 Intestinal transit time decreased PT upper gastrointestinal transit decreased 952 SLC6A4 inhibition 10010774 Constipation PT upper gastrointestinal transit decreased 952 SLC6A4 inhibition 10017944 Gastrointestinal disorder PT upper gastrointestinal transit decreased 952 TACR1 activation 10005734 Blood pressure decreased PT blood pressure decreased 953 TACR1 activation 10006482 Bronchospasm PT bronchoconstriction 954 TACR1 activation 10021518 Impaired gastric emptying PT gastric emptying decreased 955 TACR1 activation 10061218 Inflammation PT inflammation 956 TACR1 activation 10074218 Intestinal transit time increased PT intestinal transit increased 957 TACR1 activation 10017944 Gastrointestinal disorder PT intestinal transit increased 957 TACR1 activation 10012735 Diarrhoea PT intestinal transit increased 957 TACR1 activation 10033371 Pain PT pain 958 TACR1 activation 10047700 Vomiting PT vomiting 959 TACR1 inhibition 10012205 Delayed puberty PT delayed/absent sexual maturity 961 TACR1 inhibition 10005562 Blood gonadotrophin decreased PT gonadotrophic hormones decreased 962 TACR1 inhibition 10011953 Decreased activity PT locomotor activity decreased 964 TACR1 inhibition 10061296 Motor dysfunction PT locomotor activity decreased 964 TACR1 inhibition 10053469 Analgesic therapy PT pain decreased 965 TACR1 inhibition 10043306 Testicular disorder PT testicular degeneration 966 TACR2 activation 10006482 Bronchospasm PT bronchoconstriction 967 TACR2 activation 10074218 Intestinal transit time increased PT intestinal transit increased 968 TACR2 activation 10017944 Gastrointestinal disorder PT intestinal transit increased 968 TACR2 activation 10012735 Diarrhoea PT intestinal transit increased 968 TACR2 activation 10010814 Contracted bladder PT urinary bladder contractions increased 969 TACR2 inhibition 10012205 Delayed puberty PT delayed/absent sexual maturity 971 TACR2 inhibition 10074598 Intestinal transit time decreased PT intestinal transit decreased 973 TACR2 inhibition 10010774 Constipation PT intestinal transit decreased 973 TACR2 inhibition 10017944 Gastrointestinal disorder PT intestinal transit decreased 973 TACR2 inhibition 10053469 Analgesic therapy PT pain decreased 974 TACR2 inhibition 10043306 Testicular disorder PT testicular degeneration 975 TBXA2R unknown 10061218 Inflammation PT allergic inflammation 976 TBXA2R unknown 10006482 Bronchospasm PT bronchial constriction increased 977 TBXA2R unknown 10017999 Gastrointestinal pain PT gastrointestinal spasm 978 TBXA2R unknown 10035518 Platelet aggregation increased PT platelet aggregation 979 TBXA2R unknown 10046823 Uterine spasm PT uterine constriction increased 980 TBXA2R unknown 10047139 Vasoconstriction PT vascular constriction increased 981